Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2095.40-7.75 (-0.37 % )
PREV CLOSE (Rs.) 2103.15
OPEN PRICE (Rs.) 2103.15
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4152
TODAY'S LOW / HIGH (Rs.)2082.95 2116.95
52 WK LOW / HIGH (Rs.)1786.05 2455.55
NSE2095.60 -5.95 (-0.28 % )
PREV CLOSE(Rs.) 2101.55
OPEN PRICE (Rs.) 2104.90
BID PRICE (QTY) 2095.60 (223 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 67423
TODAY'S LOW / HIGH(Rs.) 2081.50 2119.80
52 WK LOW / HIGH (Rs.)1785.4 2460

Quaterly Results

(Rs in Million)
";
Particulars Mar 2021 Dec 2020 Sep 2020 Jun 2020
Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 11146.6 14098.3 13611 15344
Total Expenditure 8857.5 10429 10009.1 9460.8
PBIDT (Excl OI) 2289.1 3669.3 3601.9 5883.2
Other Income 199.2 153.8 154.5 120.9
Operating Profit 2488.3 3823.1 3756.4 6004.1
Interest 17 22.9 23.1 27.4
Exceptional Items NA NA NA NA
PBDT 2471.3 3800.2 3733.3 5976.7
Depreciation 525 535.2 521.2 510.3
Profit Before Tax 1946.3 3265 3212.1 5466.4
Tax 309.3 567.3 525.9 998.9
Provisions and contingencies NA NA NA NA
Profit After Tax 1637 2697.7 2686.2 4467.5
Extraordinary Items NA NA NA NA
Prior Period Expenses NA NA NA NA
Other Adjustments NA NA NA NA
Net Profit 1637 2697.7 2686.2 4467.5
Minority Interest 1.4 -20.9 3.7 4.5
Shares of Associates -25 -22.1 -19.2 -10.7
Other related items
Misc. Expenses Written off NA NA NA NA
Consolidated Net Profit 1613.4 2654.7 2670.7 4461.3
Equity Capital 253.7 253.7 253.7 252.7
Face Value (IN RS) 2 2 2 2
Reserves NA NA NA NA
Calculated EPS 12.71 20.92 21.05 35.30
Calculated EPS (Annualised) 50.87 83.71 84.21 141.23
No of Public Share Holdings 68135873 68135873 68135873 68135873
% of Public Share Holdings 53.71 53.71 53.93 53.93
  NA NA NA NA
PBIDTM% (Excl OI) 20.53 26.02 26.46 38.34
PBIDTM% 22.32 27.11 27.59 39.12
PBDTM% 22.17 26.95 27.42 38.95
PBTM% 17.46 23.15 23.59 35.62
PATM% 14.68 19.13 19.73 29.11
 Notes Notes Notes Notes